arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

COMPASS Pathways plc

CMPS
$13.55 ▲ +0.01 (+0.04%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
26 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
54
Health
Fair
Bullish
auto_awesome

Analytical Summary

COMPASS Pathways plc shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.5B
Dividend Yield
Revenue Growth
Op. Margin
ROIC -11.4%
FCF / Share $-0.44
Trailing P/E 19.1x
Price / Book 5.6x
FCF Yield
Debt / Equity 0.15
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$91.20M
↑ +197.1%
FCF / Share Free cash flow per share
$-0.44
↑ +14.9%
Long-Term Debt Long-term obligations
$50.48M
↑ +59.6%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Financial Health
59
Cash Quality
42

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 26 quarters